[go: up one dir, main page]

CL2017001276A1 - Derivados de benzotiazol antibacterianos - Google Patents

Derivados de benzotiazol antibacterianos

Info

Publication number
CL2017001276A1
CL2017001276A1 CL2017001276A CL2017001276A CL2017001276A1 CL 2017001276 A1 CL2017001276 A1 CL 2017001276A1 CL 2017001276 A CL2017001276 A CL 2017001276A CL 2017001276 A CL2017001276 A CL 2017001276A CL 2017001276 A1 CL2017001276 A1 CL 2017001276A1
Authority
CL
Chile
Prior art keywords
benzothiazole derivatives
antibacterial
antibacterial benzothiazole
butanamida
benzotiazol
Prior art date
Application number
CL2017001276A
Other languages
English (en)
Inventor
Azely Mirre
Jean-Luc Specklin
Jean-Philippe Surivet
Christine Schmitt
Gaélle Chapoux
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of CL2017001276A1 publication Critical patent/CL2017001276A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

<p>COMPUESTOS DERIVADOS DE BENZOTIAZOL BUTANAMIDA, COMPOSICIÓN FARMACÉUTICA QUE LOS CONTIENE Y SU USO EN LA PREVENCIÓN O EL TRATAMIENTO DE UNA INFECCIÓN BACTERIANA PRODUCIDA POR UNA BACTERIA GRAM-NEGATIVA</p>
CL2017001276A 2014-11-19 2017-05-18 Derivados de benzotiazol antibacterianos CL2017001276A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP2014075009 2014-11-19

Publications (1)

Publication Number Publication Date
CL2017001276A1 true CL2017001276A1 (es) 2018-02-16

Family

ID=54705241

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017001276A CL2017001276A1 (es) 2014-11-19 2017-05-18 Derivados de benzotiazol antibacterianos

Country Status (19)

Country Link
US (1) US20170355687A1 (es)
EP (1) EP3221300B1 (es)
JP (1) JP2018500292A (es)
KR (1) KR20170086079A (es)
CN (1) CN107001300A (es)
AR (1) AR102687A1 (es)
AU (1) AU2015349005A1 (es)
BR (1) BR112017010474A2 (es)
CA (1) CA2963875A1 (es)
CL (1) CL2017001276A1 (es)
EA (1) EA031534B1 (es)
HK (1) HK1243411A1 (es)
IL (1) IL252269A0 (es)
MX (1) MX2017006413A (es)
PH (1) PH12017500907A1 (es)
SG (1) SG11201703992YA (es)
TW (1) TW201625569A (es)
UA (1) UA118722C2 (es)
WO (1) WO2016079688A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AR105848A1 (es) * 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
CA3024756A1 (en) * 2016-05-17 2017-11-23 Idorsia Pharmaceuticals Ltd 6-(buta-1,3-diyn-1-yl)benzo[d]thiazole derivatives
CN112040947A (zh) 2017-12-07 2020-12-04 密歇根大学董事会 Nsd家族抑制剂及用其进行治疗的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50121218A (es) * 1974-03-01 1975-09-23
JPH09118660A (ja) * 1995-04-10 1997-05-06 Takeda Chem Ind Ltd 芳香族ヒドロキサム酸誘導体、製造法および剤
GB9609794D0 (en) * 1996-05-10 1996-07-17 Smithkline Beecham Plc Novel compounds
US20040224952A1 (en) 2003-05-07 2004-11-11 Cowart Marlon D. Fused bicyclic-substituted amines as histamine-3 receptor ligands
MX2007006961A (es) 2004-12-10 2007-10-04 Univ Emory Analogos nucleosidos de ciclobutilo 2' y 3'-sustituidos para el tratamiento de infeccciones virales y proliferacion celular anormal.
DE102008044132A1 (de) 2008-11-27 2010-06-02 BSH Bosch und Siemens Hausgeräte GmbH Kältegerät mit zweiseitig anschlagbarer Tür
US8372807B2 (en) 2009-05-20 2013-02-12 Ardea Biosciences, Inc. Methods of modulating uric acid levels
JP5671545B2 (ja) * 2009-10-13 2015-02-18 ファイザー・インク 抗菌薬として有用なｃ結合ヒドロキサム酸誘導体
JP5793766B2 (ja) 2009-12-16 2015-10-14 ファイザー・インク 抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体
AR083760A1 (es) 2010-11-10 2013-03-20 Achaogen Inc Agentes antibacterianos y composiciones farmaceuticas
JP2014501274A (ja) 2011-01-03 2014-01-20 ハンミ ファーム． シーオー．， エルティーディー． Ｇタンパク質共役受容体調節のための新規な二環式化合物
KR101593288B1 (ko) 2011-03-07 2016-02-11 화이자 인코포레이티드 항균제로서 유용한 플루오로-피리디논 유도체
CN103492368A (zh) * 2011-04-08 2014-01-01 辉瑞大药厂 用作抗菌剂的咪唑、吡唑和噻唑衍生物
MX2013011526A (es) 2011-04-08 2013-12-06 Pfizer Derivados de isoxazol utiles como agentes antibacteriales .
EP2847162A1 (en) 2012-05-09 2015-03-18 Achaogen, Inc. Antibacterial agents
EP2847168A1 (en) 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
MA39189A1 (fr) 2013-12-19 2017-06-30 Actelion Pharmaceuticals Ltd Dérivés de 1h-indazole et de 1h-indole antibactériens

Also Published As

Publication number Publication date
MX2017006413A (es) 2017-09-12
HK1243411A1 (zh) 2018-07-13
CN107001300A (zh) 2017-08-01
EA201791108A1 (ru) 2017-11-30
WO2016079688A1 (en) 2016-05-26
TW201625569A (zh) 2016-07-16
CA2963875A1 (en) 2016-05-26
US20170355687A1 (en) 2017-12-14
UA118722C2 (uk) 2019-02-25
EA031534B1 (ru) 2019-01-31
AR102687A1 (es) 2017-03-15
JP2018500292A (ja) 2018-01-11
EP3221300B1 (en) 2019-03-20
KR20170086079A (ko) 2017-07-25
BR112017010474A2 (pt) 2017-12-26
PH12017500907A1 (en) 2017-11-27
AU2015349005A1 (en) 2017-07-06
EP3221300A1 (en) 2017-09-27
SG11201703992YA (en) 2017-06-29
IL252269A0 (en) 2017-07-31

Similar Documents

Publication Publication Date Title
CY1121701T1 (el) Οργανικες ενωσεις μονοβακταμης για την αντιμετωπιση βακτηριακων λοιμωξεων
CL2016001524A1 (es) Derivados antibacterianos de 1h-indazol y 1h-indol.
MX2017008720A (es) Derivados y metodos para tratamiento de las infecciones por hepatitis b.
CL2016000698A1 (es) Derivados de quinolizina sustituidos útiles como inhibidores de integrasa del vih
BR112015027704A2 (pt) Composto, uso do mesmo e composição farmacêutica antibacteriana
GT201500088A (es) Derivados de 5-fenoxi-3h-pirimidin-4-ona y su uso como inhibidores de la transcriptasa inversa del vih
CL2015001864A1 (es) Compuestos derivados de espiropirido[1,2-a]pirazina sustituidos, como inhibidores de la integrasa del vih; composicion farmaceutica que los comprende; y su uso para la profilaxis o el tratamiento de una infeccion por vih.
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
MX2020003581A (es) Compuestos monobactamicos cromanos para el tratamiento de infecciones bacterianas.
BR112017002370A2 (pt) indóis para uso na infecção pelo vírus da gripe
CL2017002482A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
DOP2016000336A (es) Derivados de isoindolina para uso en el tratamiento de una infeccion viral
CL2015002755A1 (es) Composiciones antibióticas de ceftolozano.
CL2020001147A1 (es) Compuestos antibacterianos
UY36000A (es) ?compuestos microbicidas, método para controlar o prevenir la infestación de microorganismos fitopa togenos, y composición de los mismos?.
BR112016016853A2 (pt) Compostos contendo nitrogênio, seu uso e seu processo de preparação, composição farmacêutica e seu uso
CL2016000568A1 (es) Compuestos derivados de 2h-indazol-2-il-n-hidroxi-2-metilsulfonil-2-metil-butanamida sustituidos o sus sales; sus composiciones farmacéuticas que los contiene y su uso para la prevención y/o tratamiento de infecciones bacterianas gram-negativas.
CL2017001276A1 (es) Derivados de benzotiazol antibacterianos
CL2019000053A1 (es) Bacterias probióticas para peces.
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas
BR112017011980A2 (pt) composto, composição farmacêutica, e, método para tratar uma infecção bacteriana.
MX2017009094A (es) Derivado de polimixina y usos del mismo.
CL2018000228A1 (es) Nuevo antibiótico efectivo de aminoglucósido para bacterias resistentes a múltiples fármacos.
CL2017002803A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas